Header Logo

Ravi Kiran Kode

TitleProf,Clin Asst
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentCMT Internal Medicine
AddressSJKB
1802 E 19th St
Tulsa OK 74104
Fax0
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kode R, Fa K, Chowdhury S, Ranganna K, Fyfe B, Stabler S, Damask A, Laftavi MR, Kumar AM, Pankewycz O. Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. Clin Transplant. 2003 Aug; 17(4):369-76. PMID: 12868995.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    2. Kumar AM, Fa K, Vankawala R, Vora M, Kode RK, Pankewycz OG, Lattavi MR, Fyfe B, Damask AM, Ferry E, Stabler S, Tomeny MB, Phillips K, Lingaraju R, Kumar MS. Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival. Transplant Proc. 2001 Nov-Dec; 33(7-8):3195-6. PMID: 11750370.
      Citations: 3     Fields:    Translation:Humans
    3. Kumar MS, Kode RK, Pankewycz OG, Laftavi MR, Kumar AM, Damask AM, Vora M, Tomeny MB, Ferry E, Samartino BC, Sierka D, Lingaraju RM, Fyfe B. Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study. Transplant Proc. 2001 Nov-Dec; 33(7-8):3762-3. PMID: 11750602.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    4. Chowdhury S, Kode RK, Ranganna K, Damask AM, Lam A, Fyfe B, Stabler S, Kumar AM, Tomeny MB, Kumar MS, Pankewycz O. Induction strategy using basiliximab combined with mycophenolate MMF and immediate low-dose cyclosporin is steroid sparing and more effective than OKT3. Transplant Proc. 2001 Feb-Mar; 33(1-2):1057-8. PMID: 11267189.
      Citations: 3     Fields:    Translation:Humans
    5. Kode RK, Foster CE, Kumar AM, Vankawala R, Damask AM, Fyfe BS, Seirka D, Laftavi MR, Brezin J, Pankewycz O, Chvala R, Kumar MS. Nine year experience with kidney transplantation in patients with positive hepatitis C virus antibody. Transplant Proc. 2001 Feb-Mar; 33(1-2):1186-7. PMID: 11267250.
      Citations:    Fields:    Translation:Humans
    6. Kode RK, Kumar AM, Pankewycz O, Damask AM, Seirka D, Lam A, Phillips K, Ardron M, Brezin J, Chvala R, Kumar MS. Simulect induction significantly decreases CMV infection in kidney recipients compared to OKT3. Transplant Proc. 2001 Feb-Mar; 33(1-2):1268-9. PMID: 11267286.
      Citations:    Fields:    Translation:Humans
    Kode's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (38)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _